Efficient and viable synthesis development for Tiaprofenic Acid in pharmaceutical industries

 

Raghubabu K.1*, Mohan N.1, Kalyanaramu B.2, Ramadas C.3 Narayanarao M.3

1Department of Engineering Chemistry, AU College of Engineering (A), Andhra University, Visakhapatnam-530003, AP (India)

2Department of Chemistry, Maharajah’s College (Aided & Autonomous), Vizianagaram-535002, AP (India).

3Tyche Industries Limited, 11-15-28, Siris Complex, Doctors Colony,    L B Nagar, Hyderabad-500074, India

 

 

ABSTRACT:

An industrially efficient method was developed to synthesize of tiaprofenic acid (5-benzoyl-alpha-methyl-2-thiopheneacetic acid) (1) which is a very important pharmaceutical compound having anti-inflammatory and analgesic activity. Sodium salt of propionitrile is reacted with 5-benzoyl-2-bromothiophene (4) to yield nitrile crude (5) and further hydrolysis to give tiaprofenic acid (5-benzoyl-alpha-methyl-2-thiopheneacetic acid) (1).

 

KEYWORDS: Sodamide, Propionitrile, Anti-inflammatory, Tiaprofenic acid, NSAID

 

INTRODUCTION:

Tiaprofenic Acid (1) is NSAID (non-steroidal anti-inflammatory drug), similar to ibuprofen. It reduces inflammation and fever and relieves pain. Tiaprofenic Acid (1) is also used in the treatment of arthritis, headaches and menstrual cramps. Several processes for the preparation of the alpha-methyl-2-thiopheneacetic acid (2) derivatives are known.

 

All the known processes1-4 (Scheme-1) use the alpha-methyl-2-thiopheneaceticacid (2) as intermediate product.


 

 


The preparation of said intermediate shows several drawbacks being based on very laborious and low yield processes contemplating very expensive or very dangerous reactants such as sodium cyanide. We wish to report to use sodamide as base, which is easy to handle even at the production scale and the room temperature is sufficient for reaction takes place. We present an economically and industrially viable synthesis of 5-benzoyl-alpha-methyl-2-thiopheneacetic acid, which is obtained from propionitrile (3) and 5-benzoyl-2-bromothiophene (4) in two steps by employing commercially available, less expensive, nontoxic raw materials by simplified experimental conditions and isolation procedures. Sodium salt of propionitrile is reacted with 5-benzoyl-2-bromothiophene to yield nitrile crude (5) and further hydrolysis to give tiaprofenic acid (-benzoyl-alpha-methyl-2-thiopheneacetic acid) (1) (Scheme-2)

 

Preparation of 5-benzoyl-alpha-methyl-2-thiopheneacetic acid (1):

Propionitrile (10 grams, 0.1818 mol) are slowly added while maintaining the temperature between 0 and 50C to a suspension of sodamide (5 grams, 0.1282 mol) in 15ml of THF. At the end the mixture is stirred for 2 hrs at 00C. A solution separately prepared dissolving (20grms, 0.0749 mol) of 5-benzoyl–2-bromothiophene in 40ml THF is slowly added at 0-50C. The mixture was refluxed for 3 hrs and then quenched with 2 M HCl (200 ml), extracted two times with methylene dichloride (300 ml), and washed with brine (50 ml). After drying over MgSO4, the solution was filtered, concentrated by rotary evaporation to yield crude nitrile. Charged 10% aq. NaOH solution (100 ml)  and maintain 90-950C for 2 hrs and washed two times with MDC (300 ml) collected aq. layer and acidified with con HCl and stir for 3 hrs at room temperature and then filter and wash with water (100 ml). (Yield: 10.7 g, 55%, HPLC purity 98%; mp 95-970C).

 

om temperature. ith MDC.ed by rotary evaporatoin,

1H NMR (300 MHz, CDCl3) :  1.67 (d, 3H); 4.12 (m, 1H); 7.05 (d, 1H); 7.45-7.60 (m, 4H); 7.85 (d, 2H);

 

This paper describes the synthesis of tiaprofenic acid (5-benzoy-alph-methyl-2-thiopheneacetic acid) and the reagents used in the proposed synthesis are normal cost and readily available in all chemical laboratories and small scale pharmaceutical industries.

 

Acknowledgement:

The authors are thankful to Tyche Industries Limited for their continuous cooperation in this work.

 

REFERENCES:

1.     Bercot–Vatteroni M.; Moreau et R.C.; Reynaud. P.; Soc. Chem. Bull.; Fr.  1961: 1820;

2.     French Patent Application N.2398068; Canadian Patent N.1201442).

3.     Armitage B.J.; Jeffery J.E.; Nicholson J.S.; US   Pat.3959364 (Chem. Abstr., 1976; 117:131048d)

4.     Frisell C, Lawesson S. O. Organic Syntheses, 1973; 5: 642

 

 

Received on 19.10.2012

Modified on 23.10.2012

Accepted on 25.10.2012        

© A&V Publication all right reserved

Research Journal of Pharmaceutical Dosage Forms and Technology. 4(6): November–December, 2012, 318-319